BB Biotech AG (BION.SW) — the peer cohort

As of 2026-09-18 — scores re-bake nightly. Cohort = shared Closelook index membership first, then sector. Diary readings, not advice.

BB Biotech AG ranks 1 of 7 in its cohort on the Closelook composite (74/100) — the highest reading in the cohort.

NameCompositeMomentumQualityValuationSignalOff 52w high
BION.SW BB Biotech AG 74 74 96 81 info 8.2%
ARGX.BR Argen-X 65 79 75 28 ok 5.8%
ARGX argenx NV ADR 64 79 74 27 ok 7.7%
ONC BeiGene, Ltd. 63 75 63 32 ok 8.9%
REGN Regeneron Pharmaceuticals Inc 60 64 71 51 bull 8.1%
UCB.BR UCB SA 60 17 70 58 warn 27.8%
CAI Caris Life Sciences, Inc. Common Stock 59 73 60 31 ok 13.2%

Scores are relative readings across the Closelook coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-09-18

Quick answers

Who are BB Biotech AG's peers in the Closelook universe?

The cohort is drawn from shared Closelook index membership first, then sector: Argen-X (ARGX.BR), argenx NV ADR (ARGX), BeiGene, Ltd. (ONC), Regeneron Pharmaceuticals Inc (REGN), UCB SA (UCB.BR), Caris Life Sciences, Inc. Common Stock (CAI).

How does BION.SW score against its peers?

BB Biotech AG's composite reads 74/100, ranking 1 of 7 in its cohort as of 2026-09-18 — the highest in the cohort. Closelook scores are research diary readings, not ratings or advice.

Related in the Closelook universe

then Biotechnology. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.